Research Papers

25 of 470 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
A comparison of model-free phase I dose escalation designs for dual-agent combination therapies.
Barnett H; George M; Skanji D; Saint-Hilary G; Jaki T; Mozgunov P.
Stat Methods Med Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Dynamic prediction of survival using multivariate functional principal component analysis: A strict landmarking approac…
Gomon D; Putter H; Fiocco M; Signorelli M.
Stat Methods Med Res (Unknown)
Published: 2024
4/6 Transparent
Code Funding Declared
Privacy-preserving analysis of time-to-event data under nested case-control sampling.
Juwara L; Yang YA; Velly AM; Saha-Chaudhuri P.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A support vector machine-based cure rate model for interval censored data.
Pal S; Peng Y; Aselisewine W; Barui S.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clustering minimal inhibitory concentration data through Bayesian mixture models: An application to detect <i>Mycobacte…
Grazian C.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A novel rare variants association test for binary traits in family-based designs via copulas.
Dossa HRG; Bureau A; Maziade M; Lakhal-Chaieb L; Oualkacha K.
Stat Methods Med Res (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Optimal study designs for cluster randomised trials: An overview of methods and results.
Watson SI; Girling A; Hemming K.
Stat Methods Med Res (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Logistic regression vs. predictive mean matching for imputing binary covariates.
Austin PC; van Buuren S.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Local continual reassessment methods for dose finding and optimization in drug-combination trials.
Zhang J; Yan F; Wages NA; Lin R.
Stat Methods Med Res (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Compositional functional regression and isotemporal substitution analysis: Methods and application in time-use epidemio…
Jašková P; Palarea-Albaladejo J; Gába A; Dumuid D; Pedišić Ž; Pelclová J; Hron K.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Bivariate copula regression models for semi-competing risks.
Wei Y; Wojtyś M; Sorrell L; Rowe P.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Missing values and inconclusive results in diagnostic studies - A scoping review of methods.
Stahlmann K; Reitsma JB; Zapf A.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multiple imputation approaches for epoch-level accelerometer data in trials.
Tackney MS; Williamson E; Cook DG; Limb E; Harris T; Carpenter J.
Stat Methods Med Res (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials.
Scharpenberg M; Brannath W.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Negative controls: Concepts and caveats.
Penning de Vries BB; Groenwold RH.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Methods for comparative effectiveness based on time to confirmed disability progression with irregular observations in …
Debray TP; Simoneau G; Copetti M; Platt RW; Shen C; Pellegrini F; de Moor C.
Stat Methods Med Res (Unknown)
Published: 2023
5/6 Transparent
Data Code Funding Declared
Estimating transformations for evaluating diagnostic tests with covariate adjustment.
Sewak A; Hothorn T.
Stat Methods Med Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Dissecting the restricted mean time in favor of treatment.
Mao L; Wang T.
J Biopharm Stat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A robust and fast two-sample test of equal correlations with an application to differential co-expression.
He L; Philipp I; Webster S; Hjelmborg JVB; Kulminski AM.
Stat Med (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Simultaneous hypothesis testing for multiple competing risks in comparative clinical trials.
Wen J; Wang MC; Hu C.
Stat Med (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Doubly structured sparsity for grouped multivariate responses with application to functional outcome score modeling.
Huling JD; Lundine JP; Leonard JC.
Stat Med (Unknown)
Published: 2023
3/6 Transparent
Code Funding Declared
Point estimation for adaptive trial designs II: Practical considerations and guidance.
Robertson DS; Choodari-Oskooei B; Dimairo M; Flight L; Pallmann P; Jaki T.
Stat Med (Unknown)
Published: 2023
4/6 Transparent
Data Code Funding Declared
Identifying regions of interest in mammogram images.
Jiang S; Cao J; Colditz GA.
Stat Methods Med Res (Unknown)
Published: 2023
5/6 Transparent
Data Code Funding Declared
Estimating individualized treatment rules in longitudinal studies with covariate-driven observation times.
Coulombe J; Moodie EE; Shortreed SM; Renoux C.
Stat Methods Med Res (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Simulating and estimating agreement in the presence of multiple raters and covariates.
McKenzie KA; Mahnken JD.
Stat Med (Unknown)
Published: 2023
2/6 Transparent
Funding Declared